A compound score to screen patients with hereditary transthyretin amyloidosis

BACKGROUND: Hereditary transthyretin amyloidosis (ATTRv) is a rare, debilitating and fatal disease, mostly characterized by progressive axonal peripheral neuropathy. Diagnosis is still challenging and diagnostic delay in non-endemic area is about 3–4 years. The aim of this study was to arrange a cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Tozza, Stefano, Severi, Daniele, Spina, Emanuele, Di Paolantonio, Andrea, Iovino, Aniello, Guglielmino, Valeria, Aruta, Francesco, Nolano, Maria, Sabatelli, Mario, Santoro, Lucio, Luigetti, Marco, Manganelli, Fiore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293821/
https://www.ncbi.nlm.nih.gov/pubmed/35279758
http://dx.doi.org/10.1007/s00415-022-11056-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293821/
https://www.ncbi.nlm.nih.gov/pubmed/35279758
http://dx.doi.org/10.1007/s00415-022-11056-4

Ejemplares similares